Mark A. Kimak
Impact in
- Oncology top 5%
- Lymphatic System and Diseases
- Behavioral Neuroscience top 10%
Papers in
- Oncology 8
- Lymphatic System and Diseases 8
-
- Angiogenesis and VEGF in Cancer 3
- Co-authors
- Robert E. Ferrell (12 shared papers)David N. Finegold (8 shared papers)Elizabeth Lawrence (7 shared papers)Kari Alitalo (3 shared papers)Marika J. Karkkainen (3 shared papers)Michele McTigue (1 shared paper)Ahmad R. Hariri (2 shared papers)Adam X. Gorka (2 shared papers)
- Journals
- The FASEB Journal (2 papers)Lymphatic Research and Biology (2 papers)Nutrients (1 paper)Clinical Cancer Research (1 paper)BioMed Research International (1 paper)
- Partner nations
- United StatesFinlandItaly
In The Last Decade
Mark A. Kimak
14 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 93
- Oncology 743
- Behavioral Neuroscience 39
- Cellular and Molecular Neuroscience 193
- Physiology 254
- Pharmacology 165
Countries citing papers authored by Mark A. Kimak
This map shows the geographic impact of Mark A. Kimak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Kimak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Kimak more than expected).
Fields of papers citing papers by Mark A. Kimak
This network shows the impact of papers produced by Mark A. Kimak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Kimak. The network helps show where Mark A. Kimak may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark A. Kimak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 466 | |
| 2 | 2008 | 186 | |
| 3 | 2009 | 124 | |
| 4 | 2010 | 124 | |
| 5 | 2008 | 89 | |
| 6 | 2012 | 85 | |
| 7 | 2006 | 72 | |
| 8 | 2019 | 58 | |
| 9 | 2001 | 50 | |
| 10 | 2008 | 50 | |
| 11 | 2006 | 44 | |
| 12 | 2002 | 30 | |
| 13 | 2001 | 10 | |
| 14 | 2019 | 9 |
About Mark A. Kimak
Mark A. Kimak is a scholar working on Oncology, Molecular Biology, Cellular and Molecular Neuroscience, Cell Biology and Physiology, having authored 14 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lymphatic System and Diseases (8 papers), Angiogenesis and VEGF in Cancer (3 papers), Axon Guidance and Neuronal Signaling (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers), Cannabis and Cannabinoid Research (1 paper), Circadian rhythm and melatonin (1 paper), Sympathectomy and Hyperhidrosis Treatments (1 paper) and Hidradenitis Suppurativa and Treatments (1 paper). The work is most often cited by research in Oncology (743 citations), Behavioral Neuroscience (39 citations), Cellular and Molecular Neuroscience (193 citations), Physiology (254 citations) and Pharmacology (165 citations). Mark A. Kimak has collaborated with scholars based in United States, Finland and Italy. Frequent co-authors include Robert E. Ferrell, David N. Finegold, Elizabeth Lawrence, Kari Alitalo, Marika J. Karkkainen, Michele McTigue, Ahmad R. Hariri, Adam X. Gorka, Indrani Halder and Stephen B. Manuck. Their work appears in journals such as The FASEB Journal, Lymphatic Research and Biology, Nutrients, Clinical Cancer Research and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.